Difficulty: Medium
Average Score: 75%
Practice
A 29-year-old woman has a positive pregnancy test. She presents to her primary care physician for confirmation. She has a history of recurrent urinary tract infections, headaches, seizure disorder, and pulmonary embolus. Her current medications include acetaminophen, ciprofloxacin, warfarin, valproic acid, and methotrexate. Which of the following medications could be maintained at its current dose during her pregnancy?
Correct answer
A
Rationale
In this scenario, the correct answer is option A: Acetaminophen.
Acetaminophen is generally considered safe for use during pregnancy and is commonly recommended for pain relief and fever reduction. It is a category B medication, indicating that studies have not shown any risk to the fetus. Therefore, maintaining the current dose of acetaminophen during pregnancy is appropriate.
The other options, ciprofloxacin, methotrexate, and valproic acid, should not be continued at their current doses during pregnancy due to their potential harm to the developing fetus. Ciprofloxacin is an antibiotic that can pose risks to fetal cartilage development. Methotrexate is contraindicated in pregnancy as it is known to cause birth defects and pregnancy loss. Valproic acid is associated with an increased risk of congenital malformations and developmental delays in the fetus.
This question highlights the importance of considering the safety of medications during pregnancy and the need to carefully evaluate and potentially adjust a pregnant woman's medication regimen to minimize risks to both the mother and the developing fetus. Healthcare providers must be knowledgeable about medication safety in pregnancy to provide optimal care to pregnant individuals.
Acetaminophen is generally considered safe for use during pregnancy and is commonly recommended for pain relief and fever reduction. It is a category B medication, indicating that studies have not shown any risk to the fetus. Therefore, maintaining the current dose of acetaminophen during pregnancy is appropriate.
The other options, ciprofloxacin, methotrexate, and valproic acid, should not be continued at their current doses during pregnancy due to their potential harm to the developing fetus. Ciprofloxacin is an antibiotic that can pose risks to fetal cartilage development. Methotrexate is contraindicated in pregnancy as it is known to cause birth defects and pregnancy loss. Valproic acid is associated with an increased risk of congenital malformations and developmental delays in the fetus.
This question highlights the importance of considering the safety of medications during pregnancy and the need to carefully evaluate and potentially adjust a pregnant woman's medication regimen to minimize risks to both the mother and the developing fetus. Healthcare providers must be knowledgeable about medication safety in pregnancy to provide optimal care to pregnant individuals.